You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

International Prognostic Index (IPI)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Frontline of ASCT in High-risk DLBCL

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Apr 26, 2023

    18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma

    Completed
    Has Results
    • Lymphoma, Large B-Cell, Diffuse
    • FDG PET radiomic feature evaluation
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Sep 27, 2021

    Waldenstrom's Disease, Prognostic Index Trial in France

    Not yet recruiting
    • Waldenstrom's Disease
    • Prognostic Index
      • Amiens, France
      • +14 more
      Jun 12, 2023

      Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

      Completed
      Has Results
      • Non-Hodgkin's Lymphoma
      • Etoposide, carboplatin, ifosfamide
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      May 23, 2022

      ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

      Recruiting
      • Mycosis Fungoides
      • Non-Hodgkin's Lymphoma
        • Duarte, California
        • +12 more
        Jun 17, 2022

        Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma
        • Measure of the circulating tumor DNA
        • Rouen, France
          Centre Henri Becquerel
        Nov 17, 2023

        Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

        Completed
        • Posttransplant Lymphoproliferative Disorder
        • Rituximab sc
        • +3 more
        • Aachen, Germany
        • +17 more
        Aug 22, 2022

        Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

        Not yet recruiting
        • Large B-Cell Lymphoma
        • Xi'an, China
          First Affiliated Hospital of Medical College of Xi'an Jiaotong U
        Sep 14, 2023

        Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

        Completed
        • Diffuse Large B Cell Lymphoma
        • +2 more
          • (no location specified)
          Dec 13, 2021

          NHL, DLBCL Trial in Belgium, Netherlands (Atezolizumab)

          Active, not recruiting
          • NHL
          • DLBCL
          • Antwerpen, Belgium
          • +31 more
          Jan 19, 2022

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Scottsdale, Arizona
          • +2 more
          Jan 5, 2023

          Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation

          Recruiting
          • Lymphoma, Large B-Cell, Diffuse
            • Copenhagen, Denmark
              Department of Hematology, Rigshospitalet
            Jan 12, 2022

            Diffuse Large B Cell Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Zanubrutinib and RCHOP)

            Not yet recruiting
            • Diffuse Large B Cell Lymphoma
            • Rituximab, Lenalidomide, Zanubrutinib and RCHOP
            • Hangzhou, Zhejiang, China
              Zhejiang Cancer Hospital
            Mar 21, 2022

            Prognostic Value of New Markers in ALK-positive Large Anaplastic

            Recruiting
            • Anaplastic Large Cell Lymphoma, ALK-Positive
              • Amiens, France
              • +14 more
              Jul 23, 2021

              Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

              Not yet recruiting
              • Mantle Cell Lymphoma
              • (no location specified)
              Jul 26, 2023

              Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

              Not yet recruiting
              • Lymphoma, B-Cell
              • +6 more
              • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
              • Guayaquil, Guayas, Ecuador
                Instituto Oncológico Nacional Dr. Juan Tanca Marengo
              Apr 27, 2023

              A Prognostic Tool for Early Stage CLL

              Completed
              • Chronic Lymphocytic Leukemia
                • Novara, Italy
                  Azienda Ospedaliera Universitaria Maggiore della Carità
                Sep 8, 2021

                FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large

                Completed
                • Lymphoma
                • +2 more
                • FLT-PET/CT
                • +2 more
                • Los Angeles, California
                • +3 more
                May 6, 2021

                The Potential of Patient-reported Outcome Measures in Detection

                Recruiting
                • Diffuse Large B Cell Lymphoma
                • Patient Reported Outcome
                • No intervention
                • Copenhagen, Denmark
                  Therese Lassen
                Mar 18, 2022

                FODEPOC Study: Fat-free Mass Index in Copd

                Not yet recruiting
                • Chronic Obstructive Pulmonary Disease
                • Bioelectrical impedance analysis
                • (no location specified)
                May 2, 2023

                International Post-PCI FFR Extended Registry

                Completed
                • Coronary Disease
                • Percutaneous coronary intervention
                • Seoul, Korea, Republic of
                  Bon-Kwon Koo
                Jan 28, 2023

                Follicular Lymphoma ThroughProspective Collection of Data

                Completed
                • Lymphoma, Follicular
                  • Chicago, Illinois
                  • +50 more
                  Jul 7, 2020

                  B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

                  Active, not recruiting
                  • B-Cell Lymphoma
                  • Non-Hodgkin Lymphoma
                  • Birmingham, Alabama
                  • +23 more
                  Dec 2, 2022

                  Hodgkin Lymphoma Trial in Latakia (First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3

                  Recruiting
                  • Hodgkin Lymphoma
                  • First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3 and third analysis: Lymphocyte/Monocyte ratio > or = 2.9
                  • First analysis: Lymphocyte count < 1500 cells per microlitre, second analysis: IPS > or = 3 and third analysis: Lymphocyte/Monocyte ratio < 2.9
                  • Latakia, Syrian Arab Republic
                    Tishreen University
                  Feb 14, 2022

                  Endoscopy Trial in Istanbul (gastroscopy)

                  Recruiting
                  • Endoscopy
                  • gastroscopy
                  • Istanbul, Gaziosmanpaşa, Turkey
                    Gaziosmanpaşa TREH
                  Apr 13, 2023